Apogee Therapeutics, Inc. Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount
Apogee Therapeutics, Inc. (APGE) had Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount of $12.70 million as of 2023-06-30, per its 10-Q filed 2023-08-28.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions · last filed 2023-08-28
- 2023-06-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $12.70M.
| Period end | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount |
|---|---|
| 2023-06-30 | $12.70M 10-Q · filed 2023-08-28 |